1/15
07:05 am
mrkr
High Growth Tech Stocks In The US For January 2026 [Yahoo! Finance]
Medium
Report
High Growth Tech Stocks In The US For January 2026 [Yahoo! Finance]
1/14
07:36 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
1/13
07:06 am
mrkr
High Growth Tech Stocks To Watch In The US Market January 2026 [Yahoo! Finance]
Medium
Report
High Growth Tech Stocks To Watch In The US Market January 2026 [Yahoo! Finance]
1/5
07:13 am
mrkr
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer [Yahoo! Finance]
High
Report
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer [Yahoo! Finance]
1/5
07:13 am
mrkr
High Growth Tech Stocks In The US Market January 2026 [Yahoo! Finance]
High
Report
High Growth Tech Stocks In The US Market January 2026 [Yahoo! Finance]
1/5
07:00 am
mrkr
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
High
Report
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
1/2
01:04 pm
mrkr
Exploring 3 High Growth Tech Stocks In The US Market [Yahoo! Finance]
Neutral
Report
Exploring 3 High Growth Tech Stocks In The US Market [Yahoo! Finance]
1/2
06:59 am
mrkr
US High Growth Tech Stocks To Watch This January 2026 [Yahoo! Finance]
Low
Report
US High Growth Tech Stocks To Watch This January 2026 [Yahoo! Finance]
1/2
12:50 am
mrkr
US High Growth Tech Stocks to Watch [Yahoo! Finance]
Low
Report
US High Growth Tech Stocks to Watch [Yahoo! Finance]
12/31
07:01 am
mrkr
Exploring 3 High Growth Tech Stocks In The US Market [Yahoo! Finance]
Low
Report
Exploring 3 High Growth Tech Stocks In The US Market [Yahoo! Finance]
12/30
06:57 am
mrkr
Exploring High Growth Tech Stocks In The US For December 2025 [Yahoo! Finance]
Medium
Report
Exploring High Growth Tech Stocks In The US For December 2025 [Yahoo! Finance]
12/26
07:07 am
mrkr
Exploring High Growth Tech Stocks In The US December 2025 [Yahoo! Finance]
Low
Report
Exploring High Growth Tech Stocks In The US December 2025 [Yahoo! Finance]
12/25
07:02 am
mrkr
Exploring US High Growth Tech Stocks In December 2025 [Yahoo! Finance]
Medium
Report
Exploring US High Growth Tech Stocks In December 2025 [Yahoo! Finance]
12/23
12:57 pm
mrkr
High Growth Tech Stocks To Watch In US December 2025 [Yahoo! Finance]
Medium
Report
High Growth Tech Stocks To Watch In US December 2025 [Yahoo! Finance]
12/22
06:55 am
mrkr
US High Growth Tech: 3 Stocks to Watch [Yahoo! Finance]
High
Report
US High Growth Tech: 3 Stocks to Watch [Yahoo! Finance]
12/17
04:35 pm
mrkr
Marker Therapeutics (NASDAQ:MRKR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Marker Therapeutics (NASDAQ:MRKR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/9
08:11 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
12/8
11:02 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/8
09:14 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
11/30
03:33 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at
Wall Str
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) was downgraded by analysts at
Wall Str
11/20
06:02 am
mrkr
Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/14
08:10 am
mrkr
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
11/14
07:00 am
mrkr
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Medium
Report
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
11/5
07:30 am
mrkr
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
Low
Report
Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors
11/3
09:15 am
mrkr
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
Low
Report
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting